Specialty Natural Products Public Company Limited(SNPS.BK)
No price history available.
Key financial summary
Financials in THB| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | THBm | N/A | 708 | 493 | 357 | 457 | 554 | N/A | N/A |
| Operating profit | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | THBm | N/A | 170 | 78 | 37 | 81 | 112 | N/A | N/A |
| EPS reported | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | THBm | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | THB | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in THB| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Specialty Natural Products Public Company Limited manufactures and distributes herbal extracts, cosmetics, beverages, health supplements, and traditional medicines in Thailand and internationally. The company also offers extracts for nutraceuticals and cosmeceuticals for use in weight and immune control, blood pressure and sugar, antiaging, hair nourishment, whitening, wound healing, UV protection, rejuvenation for men, slimming, cosmetic mosturerizing, antibacterial, antioxidant, nutrition, and anti-inflammatory; natural additives, such as eucalyptus, ginger, jojoba, kaffir lime, lavender, lemon, lemongrass, lime, orange, peppermint, plai, turmeric, rice bran, and tea tree oil; and other additives, including amino cleansers, concentrate shampoo, SNP-alpha arbutin, Argirena, clear soap, cremaflow, emulbase, ICM, nonawax, polyol complex, solubilisant, standard EB, surfactant base1, sunsil tin50, tiospere 50BG, TOG, supersil E, and standard EB. In addition, it provides herbal active pharmaceuticals ingredients comprising senna extract liquid and andrographis extract powder; packing services for cosmetics, beverages, and dietary supplements; production and distribution of electricity; and product research and development services. The company was incorporated in 1999 and is headquartered in Chonburi, Thailand.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
Specialty Natural Products Public Company Limited (SNPS.BK)
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Specialty Natural Products Public Company Limited manufactures and distributes herbal extracts, cosmetics, beverages, health supplements, and traditional medicines in Thailand and internationally. The company also offers extracts for nutraceuticals and cosmeceuticals for use in weight and immune control, blood pressure and sugar, antiaging, hair nourishment, whitening, wound healing, UV protection, rejuvenation for men, slimming, cosmetic mosturerizing, antibacterial, antioxidant, nutrition, and anti-inflammatory; natural additives, such as eucalyptus, ginger, jojoba, kaffir lime, lavender, lemon, lemongrass, lime, orange, peppermint, plai, turmeric, rice bran, and tea tree oil; and other additives, including amino cleansers, concentrate shampoo, SNP-alpha arbutin, Argirena, clear soap, cremaflow, emulbase, ICM, nonawax, polyol complex, solubilisant, standard EB, surfactant base1, sunsil tin50, tiospere 50BG, TOG, supersil E, and standard EB. In addition, it provides herbal active pharmaceuticals ingredients comprising senna extract liquid and andrographis extract powder; packing services for cosmetics, beverages, and dietary supplements; production and distribution of electricity; and product research and development services. The company was incorporated in 1999 and is headquartered in Chonburi, Thailand.